Relation between age and clearance rate of nine investigational anticancer drugs from phase I pharmacokinetic data
JM Borkowski, M Duerr, RC Donehower… - Cancer chemotherapy …, 1994 - Springer
Aging influences the disposition and effects of several classes of drugs. Although drug
clearance rate is correlated with toxicity for many anticancer drugs, few data have been …
clearance rate is correlated with toxicity for many anticancer drugs, few data have been …
Management of prostate and bladder cancer in the elderly
R Dreicer, CS Cooper, RD Williams - Urologic Clinics, 1996 - urologic.theclinics.com
In the United States, as well as in other developed countries, the population is aging at a
significant rate. From 1960 to 1990 the number of Americans 65 years of age or older …
significant rate. From 1960 to 1990 the number of Americans 65 years of age or older …
Reducing chemotherapy-associated toxicity in elderly cancer patients
V Zagonel, L Fratino, C Sacco, R Babare… - Cancer treatment …, 1996 - Elsevier
Anticancer agents usually exhibit a relatively narrow therapeutic index, leading to significant
toxicity to normal tissues even at standard doses used in routine chemotherapy regimens (I) …
toxicity to normal tissues even at standard doses used in routine chemotherapy regimens (I) …
Defining treatment aims and end-points in older patients with cancer
CE Desch, TJ Smith - Drugs & Aging, 1995 - Springer
Mrs S is an 83-year-old woman who presents with abdominal pain and rectal bleeding. Just
before admission she returned from a Caribbean cruise where she swam daily and attended …
before admission she returned from a Caribbean cruise where she swam daily and attended …
[PDF][PDF] MİR-21, MİR-32 VE MİR-181A/B'NİN MULTİPLE MYELOMA'DA TEDAVİYE YANIT AÇISINDAN ARAŞTIRILMASI
DRS PENÇE, HHS ALSAADONİ - nek.istanbul.edu.tr
ÖZET ALSAADONI H. MiR-21, MiR-32 ve MiR-181'a/b'nin Multipl Myelom'da Tedaviye Yanıt
Açısından Araştırılması. İstanbul Üniversitesi, Sağlık Bilimleri Enstitüsü, Moleküler Tıp ABD …
Açısından Araştırılması. İstanbul Üniversitesi, Sağlık Bilimleri Enstitüsü, Moleküler Tıp ABD …
Ispitivanje citotoksičnosti kompleksa zlata i platine na ćelijskim linijama adenokarcinoma pluća in vitro i in vivo
M Arsenijević - Универзитет у Крагујевцу, 2014 - nardus.mpn.gov.rs
Lečenje tumora cisplatinom je povezano sa brojnim neželjenim efektima i relativno brzim
razvojem rezistencije. Hemioterapija NSCLC-(non small cell type) tumora pluća …
razvojem rezistencije. Hemioterapija NSCLC-(non small cell type) tumora pluća …
[引用][C] Cancer chemotherapy.
LH Smith Jr - Major Problems in Internal Medicine, 1971 - europepmc.org
Cancer chemotherapy. - Abstract - Europe PMC Sign in | Create an account https://orcid.org
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
Europe PMC Menu About Tools Developers Help Contact us Helpdesk Feedback Twitter Blog …
[引用][C] Zdravljenje raka po doktrini ali individualno?
B Jereb - Onkologija. strokovni časopis za zdravnike, 1999 - dirros.openscience.si
DOKTRINA IN AVTONOMNOST ZDRAVNIKOVEGA ODLOCANJA l< o sem se leta 1984
vrnila v domovino, sem v medicini opazila uporabo besede doktrina. Vedela sem, da je …
vrnila v domovino, sem v medicini opazila uporabo besede doktrina. Vedela sem, da je …
[引用][C] Radiation biology
R Pacelli, FJ Sullivan… - Lung cancer …, 2000 - Lippincot, Williams, & Wilkins …